stomach cancer

(Columbia University Medical Center) A multi-center research team, led by Columbia University Medical Center, has uncovered a major contributor to the cause of stomach cancer -- the second leading cause of cancer-related mortality in the world.

The team described for the first time, that elevated levels of a single proinflammatory cytokine, an immune system protein called interleukin-1 beta, can start the progression towards stomach cancer.

(Lifespan) Researchers at Rhode Island Hospital have identified two potential molecular markers that may predict outcomes for patients with stomach cancer, one of the most common and fatal cancers worldwide.

The study is published in the July 1 issue of Clinical Cancer Research.

(Oregon Health & Science University) New findings from Oregon Health & Science University Cancer Institute show significant numbers of patients nationwide who are not getting the recommended therapy after surgery to remove stomach cancer.

(Ludwig Institute for Cancer Research) Scientists at the Melbourne Branch of the international Ludwig Institute for Cancer Research have discovered what appears to be the primary driver of tumor development in the stomach.

Results published today on-line in the Journal of Clinical Investigation show that inhibiting the signaling cascade initiated by the IL-11 protein prevented the development of inflammation, hyperplasia (an abnormal increase in the number of cells) and tumor formation in pre-clinical models of gastric cancer.